Physician profile
Michael Riley
NPI 1033394747
$121,477.24
in general payments reported to CMS, 2019-2025
33 companies · $15K in 2025
The $15K reported for 2025 was more than what 86% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $2,535 · 2021: $7,993 · 2022: $25K · 2023: $35K · 2024: $19K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Food and Beverage: $17K · Travel and Lodging: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $39,000.00 |
| Food and Beverage | $16,953.32 |
| Travel and Lodging | $13,061.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $74,898.20 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Epi-Ease Epicardial Access System |
| Janssen Pharmaceuticals, INC | $18,205.65 | 2019-2024 | Xarelto |
| Medtronic, INC. | $8,582.65 | 2021-2025 | Diamondtemp Bidirectional Ablation Catheter, Affera Mapping System, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $5,987.32 | 2019-2025 | General - Therapies, Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $5,282.79 | 2020-2025 | Aveir, Jot Dx, Advisor |
| Medtronic Vascular, INC. | $1,740.19 | 2019-2020 | |
| Medical Device Business Services, INC. | $1,530.16 | 2019-2020 | |
| Ebr Systems, INC. | $1,398.93 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $485.10 | 2019-2025 | Eliquis |
| Pfizer INC. | $424.87 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $383.43 | 2023-2025 | Lifevest |
| Cvrx, INC. | $330.06 | 2021-2023 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $329.46 | 2019-2025 | |
| Davol INC. | $228.43 | 2019 | |
| W. L. Gore & Associates, INC. | $221.39 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $208.43 | 2019-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Shockwave Medical, INC | $192.02 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $156.80 | 2022-2023 | Optimizer |
| Sanofi-Aventis U.S. LLC | $147.10 | 2019-2023 | |
| Kestra Medical Technology Services, INC. | $140.28 | 2022-2025 | Assure Wcd |
| Amarin Pharma, INC. | $115.69 | 2019 | |
| Lemaitre Vascular, INC. | $101.93 | 2019-2020 | |
| Amgen INC. | $57.61 | 2019-2024 | Repatha |
| Abiomed | $55.84 | 2025 | |
| Merck Sharp & Dohme LLC | $55.19 | 2022-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.28 | 2019-2023 | Jardiance |
| Lundbeck LLC | $46.89 | 2019-2020 | |
| Bardy Diagnostics, INC. | $25.00 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $23.13 | 2023 | Uptravi |
| Otsuka America Pharmaceutical, INC. | $18.53 | 2020 | |
| Heartflow, INC. | $18.18 | 2025 | |
| United Therapeutics Corporation | $17.62 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $15.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.